Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities
Authors
Keywords
-
Journal
ARTHRITIS RESEARCH & THERAPY
Volume 13, Issue 2, Pages 215
Publisher
Springer Nature
Online
2011-04-29
DOI
10.1186/ar3280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM—Increased serum CIIM in subjects with severe radiographic osteoarthritis
- (2011) Anne-Christine Bay-Jensen et al. CLINICAL BIOCHEMISTRY
- Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs
- (2010) S. W. Syversen et al. ANNALS OF THE RHEUMATIC DISEASES
- Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers—are they the cause or the consequence of the disease?
- (2010) Morten Asser Karsdal et al. CLINICAL BIOCHEMISTRY
- Increased Sclerostin Serum Levels Associated with Bone Formation and Resorption Markers in Patients with Immobilization-Induced Bone Loss
- (2010) Agostino Gaudio et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone Marrow Edema
- (2009) Georg Schett Annals of the New York Academy of Sciences
- Opposite relationships between circulating Dkk-1 and cartilage breakdown in patients with rheumatoid arthritis and knee osteoarthritis
- (2009) N Voorzanger-Rousselot et al. ANNALS OF THE RHEUMATIC DISEASES
- Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study
- (2009) S W Syversen et al. ANNALS OF THE RHEUMATIC DISEASES
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
- (2009) D E Furst et al. ANNALS OF THE RHEUMATIC DISEASES
- Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
- (2009) Mirjam K. de Vries et al. ARTHRITIS AND RHEUMATISM
- Rapid and sustained improvement in bone and cartilage turnover markers with the antiâinterleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone
- (2009) Patrick Garnero et al. ARTHRITIS AND RHEUMATISM
- Application of biochemical markers in development of drugs for treatment of osteoarthritis
- (2009) Per Qvist et al. BIOMARKERS
- Should biochemical markers of bone turnover be considered standard practice for safety pharmacology?
- (2009) K. Henriksen et al. BIOMARKERS
- Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development
- (2009) M.A. Karsdal et al. BIOMARKERS
- Influence of food intake on the bioavailability and efficacy of oral calcitonin
- (2009) Morten A. Karsdal et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- MRI quantification of rheumatoid arthritis: Current knowledge and future perspectives
- (2009) Mikael Boesen et al. EUROPEAN JOURNAL OF RADIOLOGY
- Osteoclasts and Arthritis
- (2009) Georg Schett et al. JOURNAL OF BONE AND MINERAL RESEARCH
- High Serum Cartilage Oligomeric Matrix Protein Determines the Subset of Patients with Early-Stage Rheumatoid Arthritis with High Serum C-Reactive Protein, Matrix Metalloproteinase-3, and MRI-Proven Bone Erosion
- (2009) K. FUJIKAWA et al. JOURNAL OF RHEUMATOLOGY
- Cartilage and Bone Biomarkers in Rheumatoid Arthritis: Prediction of 10-year Radiographic Progression
- (2009) S. W. SYVERSEN et al. JOURNAL OF RHEUMATOLOGY
- Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate
- (2009) Manuel Muñoz-Torres et al. MATURITAS
- A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs
- (2009) Jun Hashimoto et al. Modern Rheumatology
- Rheumatoid arthritis associated with osteopetrosis
- (2009) Yuho Kadono et al. Modern Rheumatology
- The Helix-II epitope: a cautionary tale from a cartilage biomarker based on an invalid collagen sequence
- (2009) D.R. Eyre et al. OSTEOARTHRITIS AND CARTILAGE
- Osteoimmunology in rheumatic diseases
- (2009) Georg Schett ARTHRITIS RESEARCH & THERAPY
- Developments in the clinical understanding of rheumatoid arthritis
- (2009) Josef S Smolen et al. ARTHRITIS RESEARCH & THERAPY
- Identification of progressors in osteoarthritis by combining biochemical and MRI-based markers
- (2009) Erik B Dam et al. ARTHRITIS RESEARCH & THERAPY
- Cartilage homeostasis in health and rheumatic diseases
- (2009) Mary B Goldring et al. ARTHRITIS RESEARCH & THERAPY
- Immunoaffinity liquid chromatography–tandem mass spectrometry detection of nitrotyrosine in biological fluids: Development of a clinically translatable biomarker
- (2008) Melissa R. Radabaugh et al. ANALYTICAL BIOCHEMISTRY
- Effects of infliximab therapy on biological markers of synovium activity and cartilage breakdown in patients with rheumatoid arthritis
- (2008) H Marotte et al. ANNALS OF THE RHEUMATIC DISEASES
- Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor–transgenic mice
- (2008) Uta Schurigt et al. ARTHRITIS AND RHEUMATISM
- Erosive arthritis in a patient with pycnodysostosis: An experiment of nature
- (2008) Mari Ainola et al. ARTHRITIS AND RHEUMATISM
- Patients with rheumatoid arthritis have an altered circulatory aggrecan profile
- (2008) Jean C Rousseau et al. BMC MUSCULOSKELETAL DISORDERS
- Variation in osteoarthritis biomarkers from activity not food consumption
- (2008) Craig D. Gordon et al. CLINICA CHIMICA ACTA
- Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs
- (2008) J Avouac et al. EXPERT OPINION ON PHARMACOTHERAPY
- Significance of Serum TRACP in Rheumatoid Arthritis
- (2008) Anthony J Janckila et al. JOURNAL OF BONE AND MINERAL RESEARCH
- PIIANP and HELIXII diurnal variation
- (2008) D.J. Quintana et al. OSTEOARTHRITIS AND CARTILAGE
- Discovery and development of the N-terminal procollagen type II (NPII) biomarker: a tool for measuring collagen type II synthesis
- (2008) O.V. Nemirovskiy et al. OSTEOARTHRITIS AND CARTILAGE
- Should subchondral bone turnover be targeted when treating osteoarthritis?
- (2008) M.A. Karsdal et al. OSTEOARTHRITIS AND CARTILAGE
- Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI
- (2008) E.B. Dam et al. OSTEOARTHRITIS AND CARTILAGE
- Combination drug strategy in recent‐onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression
- (2008) M. Hakala et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity
- (2008) Morten A Karsdal et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More